High ATF4 expression correlated with tumor relapse, metastasis, and reduced overall survival of patients with breast cancer (Figure 5V–X), adenoid cystic carcinoma (ACC), osteosarcoma, glioma, and kidney renal clear cell carcinoma (KIRC; Figure S3N–Q, Supporting Information). Here, ATF4 is linked to central nervous system cancer.